TEVA PHARMACEUTICAL FIN's ticker is and the CUSIP is 88167AAE1. A total of 2 filers reported holding TEVA PHARMACEUTICAL FIN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22 | 0.0% | 25,000 | 0.0% | 0.01% | -10.0% |
| Q2 2023 | $22 | -4.3% | 25,000 | 0.0% | 0.01% | -9.1% |
| Q1 2023 | $23 | +4.5% | 25,000 | 0.0% | 0.01% | -8.3% |
| Q4 2022 | $22 | -99.9% | 25,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $21,000 | 0.0% | 25,000 | 0.0% | 0.01% | +9.1% |
| Q2 2022 | $21,000 | -8.7% | 25,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $23,000 | -4.2% | 25,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $24,000 | 0.0% | 25,000 | 0.0% | 0.01% | -8.3% |
| Q3 2021 | $24,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Highlander Capital Management, LLC | 25,000 | $22 | 0.01% |
| Pacer Advisors, Inc. | 652,000 | $583,982 | 0.00% |